Skip to main content

Research Repository

Advanced Search

Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum]

Zare, Hossein; Ahmadi, Sepideh; Ghasemi, Amir; Ghanbari, Mohammad; Rabiee, Navid; Bagherzadeh, Mojtaba; Karimi, Mahdi; Webster, Thomas J; Hamblin, Michael R; Mostafavi, Ebrahim

Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum] Thumbnail


Authors

Hossein Zare

Sepideh Ahmadi

Mohammad Ghanbari

Navid Rabiee

Mojtaba Bagherzadeh

Mahdi Karimi

Thomas J Webster

Michael R Hamblin

Ebrahim Mostafavi



Abstract

The unique properties of carbon nanotubes (CNTs) (such as their high surface to volume ratios, enhanced conductivity and strength, biocompatibility, ease of functionalization, optical properties, etc.) have led to their consideration to serve as novel drug and gene delivery carriers. CNTs are effectively taken up by many different cell types through several mechanisms. CNTs have acted as carriers of anticancer molecules (including docetaxel (DTX), doxorubicin (DOX), methotrexate (MTX), paclitaxel (PTX), and gemcitabine (GEM)), anti-inflammatory drugs, osteogenic dexamethasone (DEX) steroids, etc. In addition, the unique optical properties of CNTs have led to their use in a number of platforms for improved photo-therapy. Further, the easy surface functionalization of CNTs has prompted their use to deliver different genes, such as plasmid DNA (PDNA), micro-RNA (miRNA), and small interfering RNA (siRNA) as gene delivery vectors for various diseases such as cancers. However, despite all of these promises, the most important continuous concerns raised by scientists reside in CNT nanotoxicology and the environmental effects of CNTs, mostly because of their non-biodegradable state. Despite a lack of widespread FDA approval, CNTs have been studied for decades and plenty of in vivo and in vitro reports have been published, which are reviewed here. Lastly, this review covers the future research necessary for the field of CNT medicine to grow even further.

Citation

Zare, H., Ahmadi, S., Ghasemi, A., Ghanbari, M., Rabiee, N., Bagherzadeh, M., …Mostafavi, E. (2021). Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum]. International Journal of Nanomedicine, Volume 16, https://doi.org/10.2147/ijn.s338281

Journal Article Type Article
Acceptance Date Sep 8, 2021
Online Publication Date Oct 28, 2021
Publication Date 2021
Deposit Date Jan 25, 2022
Publicly Available Date Jan 25, 2022
Journal International Journal of Nanomedicine
Print ISSN 1176-9114
Electronic ISSN 1178-2013
Publisher Taylor and Francis Group
Peer Reviewed Peer Reviewed
Volume Volume 16
DOI https://doi.org/10.2147/ijn.s338281

Files

Published Journal Article (3.3 Mb)
PDF

Publisher Licence URL
http://creativecommons.org/licenses/by/3.0/

Copyright Statement
© 2021 Zare et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work
you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For
permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)




You might also like



Downloadable Citations